Pharmaceutical Research

, Volume 30, Issue 5, pp 1435–1446

Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in Combination with Docetaxel

Research Paper

ABSTRACT

Purpose

Evaluation of in-vivo anticancer activity of aerosolized Celecoxib encapsulated Nanolipidcarriers (Cxb-NLC) as a single therapeutic agent and combined with intravenously administered Docetaxel (Doc) against non-small cell lung cancer.

Methods

Cxb-NLC were prepared by high-pressure homogenization and were characterized for its physicochemical characteristics. Metastatic A549 tumor model in Nu/Nu mice was used to evaluate response of aerosolized Cxb-NLC & Doc. Isolated lung tumor samples were analyzed for: a) DNA fragmentation and cleaved caspase-3 by immunohistochemistry, b) apoptotic and angiogenic protein markers by western blot, c) global proteomic alterations by an isobaric labeling quantitative proteomic method and d) toxicity studies of NLC.

Results

The particle size of Cxb-NLC was 217 ± 20 nm, while entrapment efficiency was more than 90%. Cxb-NLC and Doc alone and in combination showed 25 ± 4%, 37 ± 5%, and 67 ± 4% reduction in tumor size respectively compared to control. Proteomic analysis with combination treatment further revealed significantly decreased expression of multiple pro-survival and pro-metastasis proteins as well as tumor invasion markers and the expression of S100 family proteins, such as S100A6 and S100P were decreased by 2.5 and 1.6 fold.

Conclusions

Combination therapy with Cxb-NLC and Doc showed significant reduction in tumor growth which was further confirmed by proteomic analysis.

KEY WORDS

celecoxib inhalation delivery lipid nanoparticles lung targeting nanoparticles toxicity 

Supplementary material

11095_2013_984_MOESM1_ESM.xlsx (77 kb)
Supplemental Table 1(XLSX 76 kb)
11095_2013_984_MOESM2_ESM.xlsx (52 kb)
Supplemental Table 2(XLSX 51 kb)
11095_2013_984_MOESM3_ESM.xlsx (40 kb)
Supplemental Table 3(XLSX 40 kb)

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.College of Pharmacy and Pharmaceutical SciencesFlorida A&M University,TallahasseeUSA
  2. 2.Department of Pharmaceutical Sciences, College of PharmacyUniversity of Hawaii at HiloHiloUSA
  3. 3.Department of Chemistry,Xavier University of LouisianaNew OrleansUSA

Personalised recommendations